IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Relapsed Diffuse Large B-cell Lymphoma
GWT-TUD GmbHmonoclonal_antibodyPhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
108 Active assets in the Relapsed Diffuse Large B-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Selinexor Chengdu Zenitar Biomedical Technology Co., Ltd | Phase 3 | BB |
DEXAMETHASONE City of Hope Medical Center | Phase 2/3 | BB |
Cyclophosphamide Nathan Denlinger | Phase 3 | BB |
Axicabtagene Ciloleucel Zhujiang Hospital | Phase 3 | BB |
ETOPOSIDE University of California, Davis | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →